GRX logo

The Gabelli Healthcare & Wellness Trust Stock Price

NYSE:GRX Community·US$136.0m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

GRX Share Price Performance

US$9.21
-0.21 (-2.23%)
US$9.21
-0.21 (-2.23%)
Price US$9.21

GRX Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Unattractive dividend payer with weak fundamentals.

0 Risks
0 Rewards

The Gabelli Healthcare & Wellness Trust Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$0

Other Expenses

US$0

Earnings

Last Reported Earnings
n/a
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About GRX

Founded
2007
Employees
n/a
CEO
n/a
WebsiteView website
www.gabelli.com/Template/fundinfo.cfm?tid=MTNlMzU=&bid=ZDg2&mid=NWRiNDg=&num=MzM0MGQ=&kid=NTA4NzQ=&pid=obj&rid=811-=edoc_dnuf

The Gabelli Healthcare & Wellness Trust is a closed-ended equity mutual fund launched by GAMCO Investors, Inc. The fund is managed by Gabelli Funds, LLC. It invests in the public equity markets across the globe. The fund seeks to invest in stocks of companies primarily operating in the healthcare and wellness sector. It invests in stocks of companies across all market capitalizations. The fund benchmarks the performance of its portfolio against the S&P 500 Index, S&P 500 Consumer Staples Index, and S&P 500 Health Care Index. The Gabelli Healthcare & Wellness Trust was formed on February 20, 2007 and is domiciled in the United States.

Recent GRX News & Updates

Seeking Alpha May 06

GRX: Massive Discount From This Healthcare CEF

Summary The Gabelli Healthcare & WellnessRx Trust offers defensive exposure amid 2026's tech-driven market euphoria, with the healthcare sector's resilience highlighted. GRX trades at a compelling -10% discount to NAV and features attractive valuation metrics: 15x P/E, 2.5x P/B, and 0.95x P/S. The fund's diversified portfolio spans healthcare equipment, providers, pharma, and consumer staples, with a value mid-cap tilt per Morningstar. GRX benchmarks performance against a 50/50 blend of S&P Healthcare and S&P 500 Consumer Staples, supporting its defensive positioning. Read the full article on Seeking Alpha

Recent updates

No updates